Ajooni Biotech IPO, Share Price, Shareholding and Financials

Market Sentiment

Grey Market Premium

No GMP data recorded yet for this IPO.

GMP is an informal, unregulated grey-market figure. It is not a guaranteed listing price and can move sharply during the bidding window.

Subscription

64.08x

Overall subscription

Retail 48.19x

IPO Details

Price Band	₹30 per share
Lot Size	4000 shares
Min Investment	₹1,20,000
Face Value	₹10
Total Issue Size	₹6.588 crore
Fresh Issue	₹6.588 crore
Issue Type	Fixed Price
Registrar	Cameo Corporate Services Limited
Listing At	NSE

Financial Analysis

EPS

₹1.71

P/E

10.38 x

RoE

17.12%

Net Worth

₹0.4252 Cr

Metric	2017	2016	2015
Revenue	28.58	13.23	7.22
EBITDA	0.72	0.23	0.14
Profit After Tax	0.28	0.1	0.07
Net Worth	0.96	0.51	0.43
EPS	2.89	1.85	1.71

Figures in ₹ crore unless stated otherwise (INR).

Valuation Metrics

Issue P/E

10.38 x

Price / Book

1.71

RoNW

28.76%

Mkt Cap

₹17.57 Cr

Book Value

₹18

Objects of the Issue

Purpose	Amount (₹ Cr)	%
Part-finance working capital requirements of the company	4.99	75.71
General corporate purposes	1.15	17.46
Issue-related expenses	0.45	6.83

Strengths & Risks

Strengths

Experienced promoters and a trained employee base with industry knowledge.
Established relationships with job-work service providers and raw-material suppliers.
Agreement with Patanjali Gramudyog Nyas for manufacturing and distribution of cattle feed and feed supplements with a buyback arrangement in specified states.
Own AUTUS Animal Healthcare brand supported by a dealer and distribution network across several northern Indian states.
In-house testing and quality-control capabilities and a diversified cattle-feed and animal-health supplement product portfolio.

Risks & Concerns

The company and members of its promoter group were involved in litigation or regulatory proceedings whose outcomes could adversely affect operations.
The registered office, factory and godown were operated from leased premises and were not owned by the company.
The company reported negative operating cash flows in FY2017 and FY2016 and negative cash flows in certain other periods.
Revenue was highly concentrated, with the top ten customers contributing 98.59% of revenue for the five months ended August 31, 2017.
Manufacturing disruptions, equipment failures, power interruptions or natural disasters could adversely affect production and deliveries.
The company did not generally have long-term contracts with customers and suppliers, creating risks to continuity of demand and supply.
Delayed or defaulted customer payments could result in working-capital shortages and lower profitability.
The cattle-feed and animal-supplement industry is fragmented and highly competitive, including competitors with greater financial, production and marketing resources.

Summarised from the company's own DRHP/RHP disclosures. Informational only, not investment advice — always read the full prospectus before applying.

Listing Performance

Issue Price

₹30

Listing Price

₹36

Listing Gain

+20.0%

Day High

₹36

Day Low

₹36

Day Close

₹36

Post-Listing Returns

Current Price

₹4

All-Time High

₹13

All-Time Low

₹1

1 Month

+12.9%

6 Months

+4.7%

1 Year

-28.0%

Since IPO

+0.0%

Corporate Actions

Name Changes

Effective	Old Name	New Name
27 Sep 2017	Ajooni Biotech Private Limited	Ajooni Biotech Limited

Shareholding Pattern

Quarter	Promoters	FII	DII	Public
2026-03-31	26.89	0	0	73.11

Peer Comparison

Company	Mkt Cap (₹ Cr)	P/E	RoE	EPS
Ajooni Biotech Limited	63.7	14.8	4.82	0.25
Avanti Feeds Limited	13,323	24.5	21	39.48
Hatsun Agro Product Limited	20,212	56.8	19.4	15.99

ISIN	INE820Y01021
CIN	L85190PB2010PLC040162
Incorporated	17 Feb 2010
Industry	Animal Feed
Headquarters	Mohali, Punjab
Website	www.ajoonibiotech.com

Company Timeline

Latest

29 Jun 2026

Preferential issue approved

The board approved a proposed preferential issue of up to 90 lakh shares at INR 4.30 per share to promoter Healthy Biosciences Limited, subject to approvals.

28 May 2026

FY2026 results approved

The board considered and approved audited financial results for the year ended March 31, 2026.

26 Aug 2025

Major order announced

The company announced an approximately INR 25 crore dairy-feed order from a leading Indian dairy cooperative.

06 Jun 2024

Rights shares allotted

The company allotted securities under its 2024 rights issue.

15 Dec 2022

Rights issue closed

The rights issue subscription period closed.

07 Dec 2022

Rights issue opened

A rights issue of approximately INR 29.01 crore opened at INR 6 per share.

07 Oct 2022

Stock split

The company implemented a 5-for-1 stock split, reducing face value from INR 10 to INR 2 per share.

02 Jan 2018

IPO listing

The equity shares were listed on the NSE Emerge platform.

29 Dec 2017

IPO allotment

The basis of allotment for the IPO was finalized.

22 Dec 2017

IPO closed

The IPO subscription period closed.

20 Dec 2017

IPO opened

The NSE Emerge fixed-price IPO opened at an issue price of INR 30 per share.

15 Dec 2017

Final offer document filed

The final IPO offer document was filed with the Registrar of Companies.

27 Sep 2017

Conversion to public company

The company was converted into a public limited company and renamed Ajooni Biotech Limited.

17 Feb 2010

Incorporation

The company was incorporated as Ajooni Biotech Private Limited.

Board of Directors

Name	Designation	Independent
Jasjot Singh	Chairman and Managing Director	No
Gursimran Singh	Whole-Time Director and Chief Executive Officer	No
Partek Singh	Executive Director	No
Ramandeep Singh	Non-Executive Independent Director	Yes
Imteshwar Singh Bhatia	Non-Executive Independent Director	Yes
Simmi Chhabra	Non-Executive Independent Director	Yes
Ishtneet Bhatia	Non-Executive Independent Director	Yes

Resources & Documents

Draft Red Herring Prospectus (DRHP) Prospectus Annual Report Annual Report Investor Presentation Investor Presentation

Latest News

Board approves promoter preferential issue of up to 90 lakh shares at INR 4.30 each — 29 Jun 2026 · NSE
Ajooni Biotech standalone net profit declines 38.31% in March 2026 quarter — 29 May 2026 · Business Standard
Ajooni Biotech reports FY2026 revenue of INR 184.80 crore and net income of INR 4.32 crore — 27 May 2026 · MarketScreener
Ajooni Biotech secures INR 25 crore dairy-feed order — 26 Aug 2025 · HDFC Sky

Frequently Asked Questions

What is the NSE symbol of Ajooni Biotech Limited?

The NSE symbol is AJOONI and the equity shares trade in the EQ series.

What is the ISIN of Ajooni Biotech Limited?

The ISIN is INE820Y01021.

When was the Ajooni Biotech IPO listed?

The shares were listed on the NSE Emerge platform on January 2, 2018.

What was the Ajooni Biotech IPO issue price?

The fixed IPO issue price was INR 30 per equity share of face value INR 10.

What does Ajooni Biotech Limited manufacture?

The company manufactures cattle feed, animal-feed supplements and related animal healthcare and nutrition products.

What is the promoter holding in Ajooni Biotech?

Promoter and promoter-group holding was 26.89% as of March 31, 2026.

Who are the key peers of Ajooni Biotech?

The IPO offer document identified Avanti Feeds Limited and Hatsun Agro Product Limited as listed comparison companies.

Is Ajooni Biotech covered by brokerage analysts?

No dependable active institutional analyst consensus or target price was identified.

Does Ajooni Biotech have a published ESG score?

No independently verified public ESG score was identified.

Was CSR spending mandatory for Ajooni Biotech in FY2025?

No. The FY2025 annual report stated that Section 135 CSR provisions were not applicable because the relevant financial thresholds were not met.

Last verified: 26 Jul 2026. Figures are indicative and may change; verify with official exchange filings before investing.

Ajooni Biotech Limited IPO